🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT03007589
Enrolling by invitation Not applicable

Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics

NCT03007589 · tracked via the Priya Life Science USA tracker
Sponsor
Sun Protection Foundation
Phase
Not applicable
Started
2014-04
Last updated
2025-05-15

Condition(s) studied

SunburnSun Damaged SkinOverexposure to Sun Rays

Investigational drug(s) / intervention(s)

otc sunscreenssun protection fabricsOptical Filters

otc sunscreens: Sunscreens of various SPF levels and ingredients

sun protection fabrics: fabrics

Optical Filters: Optical band pass or long pass filters or surfaces/mirrors used in solar simulators

Study summary

The purpose of this study is to assess how human skin reacts and how sunscreens and sun protection fabrics protect in natural sunlight compared to their labeled claims, indoor testing methods (existing or modified) and instructions.

Eligibility

Sex
ALL
Min age
15 Years
Max age
90 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Fitzpatrick Type I, II, III, IV or V type skin. 2. Must be able to be exposed to natural sunlight for up to 4 hours in a prone position 3. Able to read, write, speak and understand the English language. 4. Has personally read, signed, and dated the Informed Consent Form (including HIPAA disclosure) and Photograph Release 5. Generally in good health based on medical history reported by the subject 6. Healthy male or female subjects with no history or evidence of clinically relevant medical disorder, as determined from a brief medical history interview. 7. Willing and able to follow the study instructions, including: * Remain outdoors exposed to the sun or in the laboratory for up to 4 hours on Day 1 during the study with exposed skin on back protected by sunscreens and fabrics * Apply the specific sunscreens and fabrics to designated sites on the back and lie motionless. * No visual signs of recent sun exposure to the back. * No sunscreens or lotions recently used on the back. * Attend scheduled visits and intend to successfully complete the study * Stay out of the sun or stay indoors from sun exposure until after observation on Day 2. * Women are discouraged from using a bra that applies pressure to the skin site areas that may make it difficult to assess erythema or PPD on Day 2. * Refrain from using other sunscreen products or tanning bed use during the duration of the study. Exclusion Criteria: 1. Individuals with known allergies or sensitivities to sunscreens or any ingredient contained in the test products or common topical skincare products, including adhesives. 2. Perceptible erythema, PPD on the back as determined by the PI or designee. 3. Women known to be pregnant or nursing. 4. Individuals with any disease or condition of the skin (e.g., active \[i.e. flaring\] eczema or psoriasis, skin cancer, atypical nevus, polymorphic light eruption (PMLE), porphyria, systemic lupus erythematous (SLE), xeroderma pigmentosa (XP)) that could interfere with the study or increase risk to the subject. 5. Individuals with self-reported UNCONTROLLED metabolic conditions, such as diabetes, hypertension, hyper/hypothyroidism, hypercholesterolemia 6. Subjects who are taking medication for chronic conditions that may make a subject more sun sensitive (e.g., Tetracyclines, antifungals, certain diuretics, etc.) 7. Skin diseases on tested sites (e.g., photosensitivity disorders, etc.), which may influence the outcome of the study 8. An individual who has any condition which in the PI's judgment makes the candidate an inappropriate subject for study participation 9. Individuals with a condition or situation which, in the PI's opinion, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study 10. Individual viewed by the PI as not being able to complete the study

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
Sun Protection Foundation San Diego California
Sun Protection Foundation Waimea Hawaii
Sun Protection Foundation Seattle Washington
Sun Protection Foundation Santiago Chile
Sun Protection Foundation Arequipa Peru
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03007589 on ClinicalTrials.gov ↗ ← All trials in the USA